KAYLA DUSSING: Open Payments
NPI 1497141121 · FAYETTEVILLE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$785 in 36 payments from 12 companies in 2025. Trend: 2023 $449 · 2024 $480 · 2025 $785
Food & beverage: $785
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 10 | $171 |
| Amgen Inc. | 5 | $125 |
| Novartis Pharmaceuticals Corporation | 4 | $89 |
| Regeneron Healthcare Solutions, Inc. | 3 | $89 |
| AstraZeneca Pharmaceuticals LP | 4 | $74 |
| CSL Behring | 3 | $56 |
| Boston Scientific Corporation | 1 | $56 |
| Ionis Pharmaceuticals, Inc. | 1 | $32 |
| Optinose US, Inc. | 2 | $30 |
| Pharming Healthcare, Inc. | 1 | $25 |
Products named: NUCALA, TEZSPIRE, DUPIXENT, WaveWriter Alpha Prime 16, FASENRA, Haegarda, DAWNZERA, Xhance.
Industry payments across NY — which companies pay providers there.
